eli lilly news glp-1 New clinical trial data from shows its daily weight loss pill can reduce body weight by up to 11% over time. ABC medical correspondent Dr. Darien Sutton joins Linsey Davis to Lilly's new GLP-1 pill is

Application to analysis of Clinopodium vulgare L

We observed a marked decrease of gastric epithelial cell proliferation rates, protection against parietal cell death and a 90% reduction of gastritis, accompanied by normalized expression levels for all (pro-inflammatory) cytokines, confirming the suppression of the host immune response elicited by Helicobacter infection

This once-daily tablet offers a convenient alternative to injectable GLP-1 therapies

The combination of the lysosome disruptor siramesine and the tyrosine kinase inhibitor lapatinib increased the expression of TF and reduced the expression of FPN1 in breast cancer cells, thereby promoting iron overload in the lysosome and ultimately inducing ferroptosis (Ma et al., 2016)

Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity